Document Detail


Molecular pharmacology of beta-adrenoceptors.
MedLine Citation:
PMID:  2427847     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The development of radioligand-binding studies has greatly advanced our knowledge of the molecular pharmacology of beta-adrenoceptors. With this technique it is possible for the first time to directly determine the tissue concentration of beta-adrenoceptors, and by this, the responsiveness of tissues to beta-adrenergic stimulation. One major insight into the molecular pharmacology of beta-adrenoceptors to come from radioligand-binding studies was that the tissue concentration of beta-adrenoceptors is not a fixed number, but is rather dynamically regulated by a variety of drugs, hormones, physiological and pharmacological conditions. Since changes in beta-adrenoceptors assessed in circulating lymphocytes of man mirror changes in density and functional responsiveness of the corresponding myocardial beta-adrenoceptors, alterations in beta-adrenoceptor function can be also studied in human beings. In addition, by means of radioligand-binding studies the coexistence of beta 1- and beta 2-adrenoceptors has been demonstrated in numerous tissues of various species, including human heart and lung. The detailed knowledge of distribution and regulation of beta-adrenoceptors should help to improve the individual effectiveness of drug treatment.
Authors:
O E Brodde
Related Documents :
2567967 - Subtype-selective up-regulation of human saphenous vein beta 2-adrenoceptors by chronic...
17266607 - Recent advances in identification and characterization of beta-adrenoceptor agonists an...
10554207 - Effects of ripening, cultivar differences, and processing on the carotenoid composition...
21806177 - A superconducting beta spectrometer.
7539007 - Carboxyl-terminal prodomain-deleted human leukocyte elastase and cathepsin g are effici...
3027577 - Gene structure and extracellular secretion of neisseria gonorrhoeae iga protease.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  8 Suppl 4     ISSN:  0160-2446     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:  1986  
Date Detail:
Created Date:  1986-10-20     Completed Date:  1986-10-20     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  S16-20     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Dihydroalprenolol / metabolism
Humans
Iodocyanopindolol
Models, Biological
Myocardium / analysis
Pindolol / analogs & derivatives,  metabolism
Propanolamines / metabolism
Radioligand Assay
Receptors, Adrenergic, beta / metabolism*
Tissue Distribution
Chemical
Reg. No./Substance:
0/Propanolamines; 0/Receptors, Adrenergic, beta; 13523-86-9/Pindolol; 58946-16-0/iodohydroxybenzylpindolol; 60106-89-0/Dihydroalprenolol; 72795-19-8/ICI 118551; 83498-72-0/Iodocyanopindolol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A single-blind randomized comparison of the 24-h antianginal efficacy of celiprolol versus atenolol.
Next Document:  Interaction between alpha- and beta-adrenoceptor-mediated cardiovascular effects.